Advancing Cancer Care: India and BIMSTEC Join hands for a Healthier Tomorrow.

Date:

Share post:

Advancing Cancer Care: India and BIMSTEC Join hands for a Healthier Tomorrow

PharmaGenDRx News Bureau- 8th August,2025

10:00 AM IST

In a significant step toward strengthening regional health cooperation, India hosted senior Physicians, researchers and policymakers from BIMSTEC countries at the National Cancer Grid (NCG) annual meeting held on August 2 and 3,2025 at Tata Memorial Hospital, Mumbai.

The event marks the fulfillment of Prime Minister Narendra Modi’s commitment at the 6th BIMSTEC summit to support member nations in building cancer care capacities. 

Discussions were made on collaborative initiatives, virtual tumor boards, strengthening cancer registries which highlighted NCG’s wide network improving cancer care with partnering countries. It successfully demonstrated India’s leadership in healthcare diplomacy, 

India remains committed to working closely with BIMSTEC partners under the “Neighbourhood First” and “Act east” policies, ensuring shared progress in health and wellbeing, issued by MoHFW, India.

By Sharon Bose and Arundhuti Chatterjee

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

From Research to Revolution: Novo Nordisk Shares Oral GLP-1 Breakthrough Story

Novo Nordisk has shared the scientific journey behind turning an injectable biologic medicine into a pill — a...

Biozenta Lifescience to Build ₹1,250 Crore Oncology Plant in Barabanki, UP

Biozenta Lifescience Pvt. Ltd., a global leader in oncology medicines, has announced plans to establish a state-of-the-art manufacturing facility in Barabanki, Uttar...

​Zydus Collaborates with ICMR to Address Sickle Cell Disease as Desidustat Enters Phase III

Zydus Lifesciences Limited, in collaboration with the Indian Council of Medical Research (ICMR), has announced the successful completion of...

VELMENI Secures FDA Nod for Advanced AI-Driven 3D Dental Imaging

Sunnyvale, California-based dental AI firm VELMENI announced on July 23, 2026, that the U.S. FDA has granted 510(k)...